Connecting Cancer with Comfort, Compassion, Care and Commiseration

Article

What comfort can you offer when somebody tells you she or he has cancer or, more challenging, that cancer has returned or spread?

What comfort can you offer when somebody tells you she or he has cancer or, more challenging, that cancer has returned or spread? There is no etiquette book for this topic. We usually rely on our hearts. Other times, it is more the foot in the mouth that inspires. Mostly we do the best we can.

"I am so sorry!" is a good start.

Compassion informs care, commiseration and comfort. Whatever we can say that expresses our concern and sympathy will go a long way towards comforting — unless the person is not somebody who welcomes sympathy. In that case, we need to share "considerate compassion." Considerate compassion means that we consider just how much sympathy a person can handle and turn that compassion up a notch.

"I cannot begin to understand how you must be feeling," works. Let the person lead the conversation. Go with the flow.

"What can I do to help?" is another tried-and-true response, but save it for after you share some compassion.

For those of us who have experienced cancer, reactions are a little different. At the same time that we are seeking words to reach out to the person with the bad (or awful) news, inwardly we might be feeling so much empathy that we want to cringe. It is OK, I want to say, to cringe on the outside, too. There is no way to disguise the pain in our eyes when a friend or family member is surprised by a diagnosis. Empathy informs compassion.

"I feel bad about your diagnosis" is OK to say.

This is better: "Cancer is just awful, isn't it? I know you must feel bad about your diagnosis."

"I am so sorry" is always a good standby.

Commiseration is a little different than compassion. It can be awkward to commiserate too much too soon, especially when shared experiences are not analogous. I do not recommend responding with an anecdote about your migraines when somebody discloses a diagnosis of an aggressive cancer. It is not the time to talk about your aunt who had the same disease. Save that until you test the waters. Better yet, let your experience with your aunt or migraines inform how you help later.

When cancer is a bond, commiseration is inevitably wrapped up in our compassion. It might seem that the two concepts are interchangeable. "Commiseration," however, tends to be what happens when the compassion grows out of a mutual understanding of the gravity of an illness. We show compassion by sharing our experience, commiserating, without letting our experiences overshadow compassion.

"I wish that you didn't have to go through this (again)" is not a bad thing to say.

"I would do anything in my power to make life easier for you, if I could" is another.

This is more like what I might say: "What is your chemo regimen? And when do you start?"

"Let me know what questions you have about your chemo cocktail" is another.

But do not go into graphic detail about how the first time you had chemo it felt as if a freight train ran into you. Or how you broke out in splotches all over your body the second time, etc. Take the lead from the person who is sharing her news. If somebody asks you if you ever doubted yourself, or your chemo cocktail, it is OK to answer honestly. Just do not start out by sharing a sob story that will tip the scales of commiseration and make you the subject of compassion. This is not your turn for compassion.

"What is the prognosis?" is a question we might need to ask.

There are many responses from the practical (Will you need a ride to chemo?) to the philosophical (God works in mysterious ways). You will never run out of words to say if you connect a cancer announcement with comfort, compassion, care and commiseration.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content